Srinivas Rao - 02 Mar 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder & Chief Scientific Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact for Srinivas Rao
Issuer symbol
ATAI
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 14:56:54 UTC
Previous filing
24 Jun 2021
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +1,307,408 $0.000000 1,307,408 02 Mar 2022 Common Shares 1,307,408 $2.44 Direct F1
transaction ATAI Stock Option Award $0 +840,000 $0.000000 840,000 02 Mar 2022 Common Shares 840,000 $2.44 Direct F2
transaction ATAI Stock Option Award $0 +519,240 $0.000000 519,240 02 Mar 2022 Common Shares 519,240 $5.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and is exercisable as to 25% of the underlying shares on April 1, 2020, and as to 2.083% of the underlying shares in 36 monthly installments commencing on May 1, 2020.
F2 The stock option vests and is exercisable as to 25% of the underlying shares on August 21, 2021, and as to 2.083% of the underlying shares in 36 monthly installments commencing on September 1, 2021.
F3 The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

Remarks:

Co-Founder & Chief Scientific Officer